pharma · Myotonic Dystrophy Type 1 · Myotonic Dystrophy Type 1 (DM1) · DYN
Dyne Therapeutics
Dyne Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Waltham, USA HQ
2018 Founded
276 Employees
Public company Type
DYN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2018
- Employees
- 276
- Programs
- 6
- Drugs
- 11
- Patents
- 82
Dyne Therapeutics projects
2 ClinicalTrials.gov programs sponsored by Dyne Therapeutics.
Dyne Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Dyne Therapeutics have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.